PROCEPT BioRobotics Faces Securities Fraud Class Action Over Inventory Issues
News related to:PROCEPT BioRobotics Corporation · 2 min read
PROCEPT BioRobotics Corporation, a publicly traded company, is facing a securities fraud class action lawsuit following the revelation of undisclosed inventory issues and a significant stock decline. According to the lawsuit, the company failed to disclose material information during a specific period, leading to substantial financial losses for investors.
On February 25, 2026, PROCEPT BioRobotics Corporation announced its fourth fiscal quarter and year-end financial results for the period ending December 31, 2025. The company disclosed that U.S. handpiece sales had significantly exceeded the number of procedures performed in every quarter since the first fiscal quarter of 2023. This discrepancy, which grew over time, resulted in a cumulative excess field inventory of more than 10,000 units. Consequently, the company reported a significant decline in U.S. handpiece unit sales, dropping from 13,225 units in the third quarter to 9,400 units in the fourth quarter, a 30% sequential decline.
This news sent shockwaves through the market. On the day of the announcement, the price of PROCEPT BioRobotics Corporation shares fell from $27.84 to $22.69, a decline of over 18% over a two-day trading period. The stock price drop was attributed to the revelation of the inventory issues and the company's failure to disclose them earlier.
Kahn Swick & Foti, LLC, a law firm known for its work in securities litigation, is leading the class action lawsuit against PROCEPT BioRobotics Corporation. The firm is reminding investors who purchased the company's shares between February 28, 2024, and February 25, 2026, to file a lead plaintiff application by September 22, 2026, if they wish to participate in the lawsuit.
The lawsuit alleges that PROCEPT BioRobotics Corporation and certain of its executives violated federal securities laws by failing to disclose material information. The company's earnings results, which revealed the inventory issues, were seen as a significant blow to investor confidence, leading to a substantial decline in the company's stock price.
The case, titled Operating Engineers Construction Industry and Miscellaneous Pension Fund v. PROCEPT BioRobotics Corporation, is currently pending in the United States District Court for the Northern District of California. The lawsuit highlights the importance of transparency in financial reporting and the potential consequences for companies that fail to disclose material information to investors.